← Back to headlines
Pfizer and Astellas Pharma Announce Positive Results for PADCEVTM Clinical Trial
Pfizer Inc. and Astellas Pharma have announced positive results from their Phase 3 EV-304 clinical trial for the drug PADCEVTM.
1 Mar, 09:27 — 1 Mar, 09:27
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
PH records 701,884 deaths in 2024; nearly half occur outside health facilities
just now
At 52, this IRS officer can dead-lift 160 kg: ‘I started weight lifting at 45, it’s the best anti-ageing therapy’
49m ago
Stephanie Buttermore spoke about mental health weeks before sudden death; ‘no longer struggle’
49m ago
Bianca Ciobanu, provisional best MIR 2026, after Health's approval: "It is an act of justice"
1h ago